Delivery Order SPE2DB22D1017-SPE2DB23FG3UC
Award Date
9/25/23
Potential Completion Date
9/26/23
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,621.96, is for the supply of the ROTATEQ vaccine, a 2 ml dose. The contract has a firm fixed price and an ultimate completion date of December 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,033.24, is for the delivery of the ROTATEQ vaccine in 2 milliliter doses. It is a firm fixed price delivery order contract with a completion date of January 15, 2025. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $2,019.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ROTATEQ vaccine, a 2ml vaccine product. The contract is a Firm Fixed Price Delivery Order, with a completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,147.40 Firm Fixed Price Delivery Order is for the supply of the ROTATEQ VACCINE 2ML product, with a period of performance through December 12, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,950.33 firm fixed-price delivery order is for the ROTATEQ vaccine in 2-milliliter vials, with a period of performance through June 24, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the ROTATEQ vaccine in 2 milliliter volumes. The firm-fixed-price Delivery Order is valued at $2,131.20 and has a completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the ROTATEQ vaccine in 2 milliliter (ml) vials. The contract has a ceiling value of $1,664.10 and is a Firm Fixed Price Delivery Order with a final completion date of February 28, 2025. The contract award is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the ROTATEQ vaccine in 2 mL doses. The contract has a ceiling value of $1,265.40 and an ultimate completion date of May 16, 2023. This is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of the ROTATEQ vaccine, a 2-milliliter dose of the rotavirus vaccine. The $2,012.76 firm-fixed price delivery order has an ultimate completion date of December 10, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,630.29, is for the delivery of the ROTATEQ vaccine in 2 milliliter vials. This is a firm fixed-price delivery order contract with an ultimate completion date of December 10, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...